Literature DB >> 20636074

Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics.

John C Lindon1, Jeremy K Nicholson.   

Abstract

Methods for generating and interpreting metabolic profiles based on nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and chemometric analysis methods are summarized and the relative strengths and weaknesses of NMR and chromatography-coupled MS approaches are discussed. Given that all data sets measured to date only probe subsets of complex metabolic profiles, we describe recent developments for enhanced information recovery from the resulting complex data sets, including integration of NMR- and MS-based metabonomic results and combination of metabonomic data with data from proteomics, transcriptomics, and genomics. We summarize the breadth of applications, highlight some current activities, discuss the issues relating to metabonomics, and identify future trends.

Mesh:

Substances:

Year:  2008        PMID: 20636074     DOI: 10.1146/annurev.anchem.1.031207.113026

Source DB:  PubMed          Journal:  Annu Rev Anal Chem (Palo Alto Calif)        ISSN: 1936-1327            Impact factor:   10.745


  80 in total

Review 1.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

2.  Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC.

Authors:  Giovanni Blandino; Mariacristina Valerio; Mario Cioce; Federica Mori; Luca Casadei; Claudio Pulito; Andrea Sacconi; Francesca Biagioni; Giancarlo Cortese; Sergio Galanti; Cesare Manetti; Gennaro Citro; Paola Muti; Sabrina Strano
Journal:  Nat Commun       Date:  2012-05-29       Impact factor: 14.919

Review 3.  Metabolomics in pediatric nephrology: emerging concepts.

Authors:  Mina H Hanna; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2014-07-17       Impact factor: 3.714

Review 4.  Visualization of omics data for systems biology.

Authors:  Nils Gehlenborg; Seán I O'Donoghue; Nitin S Baliga; Alexander Goesmann; Matthew A Hibbs; Hiroaki Kitano; Oliver Kohlbacher; Heiko Neuweger; Reinhard Schneider; Dan Tenenbaum; Anne-Claude Gavin
Journal:  Nat Methods       Date:  2010-03       Impact factor: 28.547

5.  Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.

Authors:  Pascal Mercier; Michael J Lewis; David Chang; David Baker; David S Wishart
Journal:  J Biomol NMR       Date:  2011-03-01       Impact factor: 2.835

Review 6.  Nuclear magnetic resonance based metabolomics and liver diseases: Recent advances and future clinical applications.

Authors:  Roland Amathieu; Mohamed Nawfal Triba; Corentine Goossens; Nadia Bouchemal; Pierre Nahon; Philippe Savarin; Laurence Le Moyec
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  Plasma metabonomics study of the patients with acute anterior uveitis based on ultra-performance liquid chromatography-mass spectrometry.

Authors:  Junguo Guo; Tingqin Yan; Hongsheng Bi; Xiaofeng Xie; Xingrong Wang; Dadong Guo; Haiqiang Jiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-08       Impact factor: 3.117

8.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

Review 9.  Metabolic phenotyping in clinical and surgical environments.

Authors:  Jeremy K Nicholson; Elaine Holmes; James M Kinross; Ara W Darzi; Zoltan Takats; John C Lindon
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

10.  Biomarker Discovery and Translation in Metabolomics.

Authors:  G A Nagana Gowda; D Raftery
Journal:  Curr Metabolomics       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.